Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘hedge fund:408’

Covalis Capital's Returns, AUM and Holdings

Hedge Fund and Insider Trading News: Ray Dalio, Nelson Peltz, Weight Watchers International, Inc. (WTW), Xeris Pharmaceuticals Inc (XERS), Carolina Financial Corporation (CARO), and More

‘Pain + Reflection = Progress’: Here are 13 Brilliant Quotes from Hedge-fund Legend Ray Dalio (Business Insider) Hedge fund legend Ray Dalio, who......(read more)
stock, market, buy, graph, risk, trading, dice, concepts, chart, objects, investment, opportunity, business, three-dimensional, horizontal, line, gambling, decisions, symbol,

Hedge Fund and Insider Trading News: Stanley Druckenmiller, David Tepper, Constellation Pharmaceuticals Inc (CNST), BIOLASE Inc (BIOL), Novocure Ltd (NVCR), and a Lot More

Billionaires Druckenmiller, Soros Throw Weight Behind Oil Rally (Bloomberg) The recovery in the oil industry is attracting some of the most recognized......(read more)
Countries with the Smallest Government Per Capita in the WorldCountries with the Smallest Government Per Capita in the World

Hedge Fund and Insider Trading News: Eddie Lampert, Elliott Management, Limelight Networks, Inc. (LLNW), The New York Times Company (NYT), Spectrum Pharmaceuticals, Inc. (SPPI), and More

Eddie Lampert is Seeking to Sell Sears Assets to his Hedge Fund – This will be Bad for Sears (Verdict.co.uk) In wanting to sell Sears’ assets......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

13D Filing: James E. Flynn and Homology Medicines Inc (FIXX)

Homology Medicines Inc (NASDAQ:FIXX): James E. Flynn filed an amended 13D. You can check out Deerfield Management’s latest holdings and filings......(read more)
Quickest and Easiest Masters Degrees to Get Online

13D Filing: James E. Flynn and DFB Healthcare Acquisitions Corp.

DFB Healthcare Acquisitions Corp.: James E. Flynn filed an amended 13D. You can check out Deerfield Management’s latest holdings and filings here......(read more)
25 Most Expensive Countries in the World in 2017

13D Filing: James E. Flynn and DFB Healthcare Acquisitions Corp.

DFB Healthcare Acquisitions Corp.: James E. Flynn filed an amended 13D. You can check out Deerfield Management’s latest holdings and filings here......(read more)
Countries With Highest Medical Research Spending

13G Filing: James E. Flynn and Natera Inc. (NTRA)

Natera Inc. (NASDAQ:NTRA): James E. Flynn’s Deerfield Management filed an amended 13D. You can check out Deerfield Management’s latest holdings......(read more)
Copyright: nexusplexus / 123RF Stock Photo

13D Filing: James E. Flynn and Proteon Therapeutics Inc (PRTO)

Proteon Therapeutics Inc (NASDAQ:PRTO): James E. Flynn’s Deerfield Management filed an amended 13D. You can check out Deerfield Management’......(read more)
Pressmaster/Shutterstock.com

13D Filing: James E. Flynn and AveXis Inc (AVXS)

AveXis Inc (NASDAQ:AVXS): James E. Flynn’s Deerfield Management filed an amended 13D. You can check out Deerfield Management’s latest holdings......(read more)
pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, drugstore, service,

13G Filing: James E. Flynn and Mallinckrodt PLC (MNK)

Mallinckrodt PLC (NYSE:MNK): James E. Flynn’s Deerfield Management filed an amended 13D. You can check out Deerfield Management’s latest holdings......(read more)
pharmacist, worker, shelves, business, counter, glasses, attractive, medical, competence, chemist, adult, clinic, drugstore, selling, female, consultation, medicine, coat

13G Filing: James E. Flynn and Lannett Co Inc (LCI)

Lannett Co Inc (NYSE:LCI): James E. Flynn’s Deerfield Management filed an amended 13D. You can check out Deerfield Management’s latest holdings......(read more)
biotech research company, bio-technology companies

13G Filing: James E. Flynn and Aclaris Therapeutics Inc (ACRS)

Aclaris Therapeutics Inc (NASDAQ:ACRS): James E. Flynn’s Deerfield Management filed an amended 13D. You can check out Deerfield Management’......(read more)
Pressmaster/Shutterstock.com

13D Filing: James E. Flynn and AveXis Inc (AVXS)

AveXis Inc (NASDAQ:AVXS): James E. Flynn’s Deerfield Management filed an amended 13D. You can check out Deerfield Management’s latest holdings......(read more)
Sergey Nivens/Shutterstock.com

13G Filing: James E. Flynn and Mirna Therapeutics Inc. (MIRN)

Mirna Therapeutics Inc. (NASDAQ:MIRN): James E. Flynn’s Deerfield Management filed an amended 13D. You can check out Deerfield Management’......(read more)
Easiest Md/PhD Programs to Get Into

13G Filing: James E. Flynn and Neos Therapeutics Inc (NEOS)

Neos Therapeutics Inc (NASDAQ:NEOS): James E. Flynn’s Deerfield Management filed an amended 13D. You can check out Deerfield Management’s......(read more)
biotech research company, bio-technology companies

13G Filing: James E. Flynn and Ardelyx Inc. (ARDX)

Ardelyx Inc (NASDAQ:ARDX): James E. Flynn’s Deerfield Management filed an amended 13D. You can check out Deerfield Management’s latest holdings......(read more)
Pressmaster/Shutterstock.com

13D Filing: James E. Flynn and AveXis Inc (AVXS)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 15 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington......(read more)
biotech research company, bio-technology companies

13D Filing: James E. Flynn and Proteon Therapeutics Inc (PRTO)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 14 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington......(read more)
30 Funniest Science Jokes, Puns, and Humor Quotes Ever

13D Filing: James E. Flynn and Alpine Immune Sciences Inc. (ALPN)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington......(read more)
James Flynn Deerfield Management

13D Filing: James E. Flynn and Proteon Therapeutics Inc (PRTO)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 20 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington......(read more)
James Flynn Deerfield Management

13D Filing: James E. Flynn and Alpine Immune Sciences Inc. (ALPN)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 15 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

13G Filing: James E. Flynn and Marinus Pharmaceuticals Inc (MRNS)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing SECURITIES AND EXCHANGE COMMISSION WASHINGTON......(read more)
James Flynn Deerfield Management

13G Filing: James E. Flynn and Biocryst Pharmaceuticals Inc (BCRX)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 14 – SEC Filing SECURITIES AND EXCHANGE COMMISSION WASHINGTON......(read more)
James Flynn Deerfield Management

13D Filing: James E. Flynn and AveXis Inc (AVXS)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 15 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington......(read more)
James Flynn Deerfield Management

13G Filing: James E. Flynn and Biocryst Pharmaceuticals Inc (BCRX)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 14 – SEC Filing SECURITIES AND EXCHANGE COMMISSION WASHINGTON......(read more)
James Flynn Deerfield Management

13D Filing: James E. Flynn and Adeptus Health Inc. (ADPT)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 11 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington......(read more)
James Flynn Deerfield Management

13G Filing: James E. Flynn and Ehealth Inc. (EHTH)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 14 – SEC Filing SECURITIES AND EXCHANGE COMMISSION WASHINGTON......(read more)
James Flynn Deerfield Management

13G Filing: James E. Flynn and Proteon Therapeutics Inc (PRTO)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 19 – SEC Filing SECURITIES AND EXCHANGE COMMISSION WASHINGTON......(read more)
James Flynn Deerfield Management

13G Filing: James E. Flynn and Audentes Therapeutics Inc (BOLD)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 18 – SEC Filing   SECURITIES AND EXCHANGE COMMISSION......(read more)
James Flynn Deerfield Management

13D Filing: James E. Flynn and Nivalis Therapeutics Inc. (NVLS)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 16 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington......(read more)
James Flynn Deerfield Management

13D Filing: James E. Flynn and Adeptus Health Inc. (ADPT)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 8 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington......(read more)
James Flynn Deerfield Management

13G Filing: James E. Flynn and Mannkind Corp (MNKD)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing   SECURITIES AND EXCHANGE COMMISSION......(read more)
James Flynn Deerfield Management

13D Filing: James E Flynn and Adeptus Health Inc. (NYSE:ADPT)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 8 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington......(read more)
Can hedge funds beat the market

140 Biggest and Most Famous Activist Hedge Funds

Some of the names we are going to show on this top 140 biggest and most famous activist hedge funds list are the investors that keep certain executives......(read more)
Bill Ackman, Pershing Square Capital Management, Herbalife

Hedge Fund News: Bill Ackman, Deerfield Management, Elliott Management

Bill Ackman Is Moving His Office To Hell’s Kitchen (CNBC) It’s official: Hedge fund titan Bill Ackman is moving Pershing Square Capital to......(read more)
James Flynn Deerfield Management

Blueprint Medicines Corp (BPMC) Stock: Deerfield Management Reports New 4.51% Stake

A new 13G filing with the Securities and Exchange Commission revealed that James E. Flynn‘s Deerfield Management has acquired 1.23 million common......(read more)
James Flynn Deerfield Management

Vanda Pharmaceuticals Inc. (VNDA) Stock: Deerfield Management Cashes In 2.56 Million Shares

According to a freshly-amended 13G filing with the Securities and Exchange Commission, James E. Flynn‘s Deerfield Management has sold around......(read more)
James Flynn Deerfield Management

Catabasis Pharmaceuticals Inc (CATB): Deerfield Management Adds to Its Position

James E. Flynn‘s Deerfield Management recently filed a Form 13G with the SEC in which it reported holding 783,375 common shares of Catabasis Pharmaceuticals......(read more)
emergency, room, doctor, sick, group, latin, medical, profession, patient, doc, concept, life, middle, clinic, male, corridor, occupation, service, gurney, ill, worker, female,

Adeptus Health Inc. (ADPT): James E. Flynn’s Deerfield Management Monitoring Search for New CEO

James E. Flynn, manager of Deerfield Management, recently contacted Gregory W. Scott, a member of the Board of Adeptus Health Inc. (NYSE:ADPT) concerning......(read more)
pharmaceuticals-385956_1280

5 Stocks That Healthcare Fund Deerfield Management Was Buying in Q2

Founded by James E. Flynn in 2000, Deerfield Management has grown to become one of the premier healthcare-focused investment management companies today......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Deerfield Management Discloses Stake In Post-IPO Audentes Therapeutics (BOLD)

James E. Flynn and his fund, Deerfield Management, have disclosed a stake in Audentes Therapeutics Inc (NASDAQ:BOLD), a company that has recently closed......(read more)
James Flynn Deerfield Management

Syros Pharmaceuticals (SYRS): Deerfield Management Discloses Position

James E. Flynn‘s Deerfield Management has disclosed a stake in Syros Pharmaceuticals Inc (NASDAQ:SYRS), a biotechnology company recently gone......(read more)
James Flynn Deerfield Management

Portola Pharmaceuticals Inc (PTLA): This Hedge Fund is Loading Up Following Stock’s Weakness

It’s been a disastrous year for Portola Pharmaceuticals Inc (NASDAQ:PTLA) thus far, as the company has shed over 60% of its value year-to-date.......(read more)
James Flynn Deerfield Management

13D Filing: James Flynn’s Deerfield Management Takes 9.99% Stake in Newly-Public AveXis, Inc. (AVXS)

AveXis Inc (NASDAQ:AVXS) is the subject of a new 13D filing issued by James Flynn‘s Deerfield Management, which reveals a 2.24 million-share position......(read more)
Paul Singer ELLIOTT MANAGEMENT

Billionaire Singer Lifts Stake in Cabelas Inc. (CAB), Deerfield Bets on Beloranib, Plus Two Other Moves

Numerous closely-watched hedge fund vehicles are currently disclosing their equity positions as of the end of 2015, so individual investors can monitor......(read more)
James Flynn Deerfield Management

13G Filing: Deerfield Management Reveals 5% Stake in Newly-Public Editas Medicine, Inc. (EDIT)

Form 13G’s must be filed with the SEC upon any investor or entity amassing at least 5% of a company’s outstanding shares, or alternatively......(read more)
James Flynn Deerfield Management

Billionaires James Flynn, David Abrams, Among the Elite Investors Buying These 4 Stocks Last Week

Individual investors might find hedge fund investing quite expensive, considering the 2-and-2o fee structure most hedge funds employ. However, mimicking......(read more)
Keith Meister, Corvex Capital

A Look At Smart Money Three Latest Moves

In new filings with the U.S. Securities and Exchange Commission, Kelly Cardwell’s Central Square Management, James E. Flynn’s Deerfield Management......(read more)
stocks, analysis, market, numbers, business, ticker, trade, money, price, investment, index, chart

Smart Money Is Seeing Upside For These Three Companies

Three companies have recently been the subject of bullish moves by hedge funds. Let us take a look at what makes these companies seem undervalued to hedgies......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

A Look at Top Picks of This Billion-Dollar Healthcare-Focused Fund

Deerfield Management, a healthcare-focused fund managed by James E. Flynn  has issued its 13F filing for the end of the third quarter, revealing an......(read more)